HTA is multi-disciplinary field of policy analysis that examines the medical, economic, social and ethical implications of the incremental value, diffusion and use of a health technology in health care.
The term Health Technology refers to application of organised knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of life.
This report evaluates the current state of evidence regarding effectiveness and harms of catheter ablation for atrial fibrillation (AF) with a focus on longer-term outcomes and evidence relevant to the Medicare population. Using predefined criteria, randomized trials and observational studies comparing the efficacy, effectiveness, or safety of catheter ablation (radiofrequency or cryoballoon ablation) to medical therapy […]
Left ventricular assist device (LVAD) is considered an alternative to transplantationin end stage acute or chronic left ventricular congestive heart failure (HF). Use of LVAD improves the allocation of transplants alleviating the shortage of donors. The target population of the technology is represented by patients with end stage heart failure. Objectives: To assess the effect of using a […]
Peripheral arterial disease is a condition in which atherosclerotic plaques partially or completely block blood flow to the legs. Although percutaneous transluminal angioplasty and metallic stenting have high immediate success rates in treating peripheral arterial disease, long-term patency and restenosis rates in long and complex lesions remain unsatisfactory. The objective of this analysis was to evaluate the […]
Atrial fibrillation (AF) is the most common arrhythmia seen in general practice and is associated with a five-fold increase in the risk of stroke. Strokes related to atrial fibrillation are also more severe, with twice the death rate of non-AF related strokes and greater functional deficits for those who do survive. Irish data suggest that almost […]
On 25 July 2013, the then Minister for Health, Dr James Reilly, requested that the Health Information and Quality Authority undertake a health technology assessment (HTA) of a public access defibrillation programme. This was with the aim of informing decision-making on matters related to the Public Health (Availability of Defibrillators) Bill 2013. The Bill lists the […]
Implantable cardioverter–defibrillators (ICDs) are battery-powered implantable devices that monitor heart rhythm and deliver therapy in the form of either electric shock or antitachycardia pacing (ATP) when a life-threatening ventricular arrhythmia is detected. ICDs have been used in patients who survived sustained ventricular arrhythmias to prevent sudden cardiac death (SCD). In recent years, ICDs have also been […]
DBS is a surgical procedure for the relief of motor function symptoms in patients with movement disorders – including Parkinson‟s disease, essential tremor and dystonia – that are no longer adequately controlled by drug therapy. At present, patients deemed suitable for DBS are routinely referred to UK DBS centres for treatment. Funding is provided through the […]
The primary objectives of this Health Technology Assessment (HTA) were to assess clinical outcomes (clinician- and patient-based) of ball-type mandibular two-implant overdenture treatment in comparison to treatment with: 1) removable mandibular complete dentures, 2) different types of attachments for mandibular two-implant overdenture, and 3) different loading protocols of the mandibular overdenture. The secondary objective was to conduct a cost analysis […]
Transcatheter aortic valve implantation (TAVI) has become an alternative to surgical aortic valve replacement (sAVR) for patients at high risk for surgery. The objective of this analysis is to evaluate the safety, effectiveness, and cost-effectiveness of transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis (AVS) in symptomatic older adults. AVS can result from the progressive build-up […]
The objective of this Medical Advisory Secretariat (MAS) report was to conduct a systematic review of the available published evidence on the safety, effectiveness, and cost-effectiveness of Internet-based device-assisted remote monitoring systems (RMSs) for therapeutic cardiac implantable electronic devices (CIEDs) such as pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The MAS evidence-based review was performed to […]